SEC Filing Summary: Predictive Oncology Inc. (POAI)
Business Context and Reporting Period
This Form 8-K Current Report was filed by Predictive Oncology Inc. (not Axe Compute Inc.) on October 16, 2025. The filing addresses Item 5.08 regarding Shareholder Director Nominations and the scheduling of the 2025 Annual Meeting of Stockholders.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is a procedural notice regarding corporate governance and does not contain financial performance data.
Material Changes
No material financial changes are reported. The primary event is the formal announcement of the 2025 Annual Meeting schedule and the establishment of deadlines for stockholder proposals.
Guidance, Outlook, and Management Commentary
- Annual Meeting Date: November 25, 2025.
- Location: DLA Piper LLP (US), 1001 Liberty Avenue, Suite 500, Pittsburgh, Pennsylvania 15222.
- Record Date: October 24, 2025 (for determining stockholders entitled to vote).
- Proposal Deadline: October 26, 2025 (for stockholder proposals and proxy access requests).
- Proxy Materials: Anticipated mailing on or about November 3, 2025.
- Management Action: The Company undertakes to supplement proxy materials or postpone the meeting if necessary to address timely received proposals.
Key Facts for Investor Verification
- Verify the Record Date of October 24, 2025 to ensure eligibility to vote at the upcoming Annual Meeting.
- Note the Proposal Deadline of October 26, 2025 for submitting any stockholder proposals or proxy access requests.
- Confirm the meeting location at DLA Piper LLP (US) in Pittsburgh, PA, rather than the company's principal executive offices.
- Be aware that definitive proxy materials are expected to be mailed around November 3, 2025.